Moscow, December 1, 2014– Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) announces that the Company decided to release Igor Krylov from the Acting CEO of Pharmstandard OJSC and to appoint Vladimir Chupikov as an interim CEO of the Company.

Previously, Mr.Chupikov held the position of a Deputy CEO for Procurement.

Contacts:

Irina Bakhturina

Head of Investor Relations

Pharmstandard OJSC

Tel: +7 495 970 0030 ext. 2824

E-mail:ir@pharmstd.ru 

About Pharmstandard:

Pharmstandard OJSC (www.pharmstd.com) – Russia’s leading pharmaceutical Company that develops and manufactures high-quality modern pharmaceutical products which meet the requirements of the healthcare system and the expectations of patients. 

The Company’s production assets consist of 8 pharmaceutical plants located in Kursk, Ufa, Tomsk, Vladimir and in Ukraine’s Kharkov and 1 medical equipment plant in Tyumen. 

Pharmstandard shares and GDRs are traded on the RTS-MICEX and LSE, respectively. 

www.pharmstd.ru